Dr. Gunes Ekin Atilla-Gokcumen's lab focuses on understanding the health risks associated with per- and polyfluoroalkyl substances (PFAS), a group of chemicals that contaminate our environment and affect human health. The lab investigates how PFAS exposure impacts brain development and function, particularly in relation to neurodevelopmental disorders like autism and ADHD. They use zebrafish models and various experimental techniques to uncover the cellular mechanisms of PFAS uptake and its neurotoxic effects.

Dr. Chelsie Armbruster's lab focuses on understanding urinary tract infections (UTIs), particularly those associated with catheter use. They explore how certain bacteria interact with the urinary tract and the role of glycosaminoglycans, a protective layer in the bladder, in infection and immune responses. The lab aims to discover new ways to prevent these infections, especially in vulnerable populations, by studying bacterial behavior and the infection process.

Dr. Yongho Bae's lab focuses on understanding how the stiffness of blood vessels influences the behavior of vascular smooth muscle cells, which play a crucial role in cardiovascular diseases. The research aims to uncover the molecular mechanisms behind this relationship, particularly the role of a protein called survivin. By using advanced cell culture techniques and mouse models, the lab seeks to identify new therapeutic targets to prevent vascular-related conditions and improve heart health.

Dr. Yun Wu's lab focuses on developing innovative methods for early lung cancer detection and monitoring patients' responses to immunotherapy treatments. By utilizing a non-invasive liquid biopsy approach called the Exo-PROS assay, the team aims to identify specific biomarkers from tumor-derived exosomes found in blood samples. This research seeks to improve the accuracy and effectiveness of lung cancer diagnostics, ultimately enhancing patient outcomes through better treatment strategies.